Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Hepatotoxicity of Tyrosine Kinase Inhibitors: Clinical and Regulatory Perspectives
HTML
Details
Locations
Year:
2013
Type:
review
Source:
Drug Safety
DOI:
10.1007/s40264-013-0048-4
Authors:
Rashmi R. Shah,
Joel Morganroth,
Devron R. Shah
Language:
English
Topic:
Drug-Induced Hepatotoxicity and Protection
Subfield:
Pharmacology
Field:
Pharmacology, Toxicology and Pharmaceutics
Domain:
Life Sciences
Keywords:
tyrosine kinase inhibitors,
drug-induced liver injury,
liver injury,
lapatinib,
pazopanib,
ponatinib,
regorafenib,
sunitinib,
imatinib,
sorafenib,
black box warning,
pharmacovigilance,
dose adjustment,
drug interactions,
liver metastasis,
risk-benefit assessment
show all 16
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W2065902287
FWCI:
2.632
Cites:
94
Cited by:
267
Related to:
10